PH30305A - Improved meningococcal polysaccharide conjugate vaccine - Google Patents
Improved meningococcal polysaccharide conjugate vaccineInfo
- Publication number
- PH30305A PH30305A PH41724A PH41724A PH30305A PH 30305 A PH30305 A PH 30305A PH 41724 A PH41724 A PH 41724A PH 41724 A PH41724 A PH 41724A PH 30305 A PH30305 A PH 30305A
- Authority
- PH
- Philippines
- Prior art keywords
- conjugate vaccine
- polysaccharide conjugate
- meningococcal polysaccharide
- improved
- improved meningococcal
- Prior art date
Links
- 108010060123 Conjugate Vaccines Proteins 0.000 title 1
- 229940031670 conjugate vaccine Drugs 0.000 title 1
- 150000004676 glycans Chemical class 0.000 title 1
- 229920001282 polysaccharide Polymers 0.000 title 1
- 239000005017 polysaccharide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44819589A | 1989-12-14 | 1989-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH30305A true PH30305A (en) | 1997-02-20 |
Family
ID=23779371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH41724A PH30305A (en) | 1989-12-14 | 1990-12-14 | Improved meningococcal polysaccharide conjugate vaccine |
Country Status (30)
Country | Link |
---|---|
US (3) | US5576002A (fr) |
EP (1) | EP0504202B1 (fr) |
JP (1) | JP2637845B2 (fr) |
KR (1) | KR0158436B1 (fr) |
CN (4) | CN1049223C (fr) |
AR (1) | AR243934A1 (fr) |
AT (1) | ATE121947T1 (fr) |
AU (1) | AU641715B2 (fr) |
BR (1) | BR9007917A (fr) |
CA (1) | CA2071811C (fr) |
CZ (1) | CZ283530B6 (fr) |
DE (1) | DE69019164T2 (fr) |
DK (1) | DK0504202T3 (fr) |
ES (1) | ES2071288T3 (fr) |
FI (2) | FI104539B (fr) |
HR (1) | HRP920872A2 (fr) |
HU (2) | HU9201966D0 (fr) |
IE (1) | IE68414B1 (fr) |
IL (1) | IL96676A (fr) |
IN (1) | IN171747B (fr) |
NO (2) | NO305275B1 (fr) |
NZ (1) | NZ236471A (fr) |
PH (1) | PH30305A (fr) |
PL (2) | PL166659B1 (fr) |
RO (1) | RO111416B1 (fr) |
RU (1) | RU2105568C1 (fr) |
SI (1) | SI20008B (fr) |
WO (1) | WO1991008772A1 (fr) |
YU (1) | YU24391A (fr) |
ZA (1) | ZA9010065B (fr) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648241A (en) * | 1989-09-15 | 1997-07-15 | The General Hospital Corporation | Conjugate vaccine against group B streptococcus |
WO1991008772A1 (fr) * | 1989-12-14 | 1991-06-27 | National Research Council Of Canada | Vaccin conjugue ameliore a base de polysaccharide de meningocoque |
NZ248766A (en) * | 1992-09-24 | 1996-11-26 | Ca Nat Research Council | Capsular polysaccharide-protein conjugate vaccine against group b streptococcus type ii or v |
US6153406A (en) * | 1993-07-23 | 2000-11-28 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B |
US5439808A (en) * | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
US5700787A (en) * | 1994-09-02 | 1997-12-23 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
US5679654A (en) * | 1994-09-02 | 1997-10-21 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
US5747287A (en) * | 1995-04-28 | 1998-05-05 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
PT1090642E (pt) * | 1995-06-07 | 2008-09-09 | Glaxosmithkline Biolog Sa | Vacinas compreendendo um conjugado de antigénio polissacarídico - proteína veículo e proteína veículo livre |
US5811102A (en) | 1995-06-07 | 1998-09-22 | National Research Council Of Canada | Modified meningococcal polysaccharide conjugate vaccines |
US6284884B1 (en) | 1995-06-07 | 2001-09-04 | North American Vaccine, Inc. | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
ZA97248B (en) * | 1996-01-18 | 1997-07-18 | Rohm & Haas | Method for identifying and quantifying polymers utilizing immunoassay techniques |
WO1998008874A1 (fr) | 1996-08-27 | 1998-03-05 | Chiron Corporation | Anticorps monoclonaux definissant des epitopes meningococciques b et leurs utilisations dans la preparation de compositions vaccinales |
EP0939647B2 (fr) | 1996-08-27 | 2006-07-12 | Chiron Corporation | Glycoconjugues du groupe serologique b de neisseria meningitidis et procedes pour leur utilisation |
US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
US6413520B1 (en) | 1997-06-24 | 2002-07-02 | Chiron Corporation | Methods of immunizing adults using anti-meningococcal vaccine compositions |
CA2301942C (fr) * | 1997-08-27 | 2011-05-31 | Chiron Corporation | Mimetiques moleculaires des epitopes b meningococciques |
EP1051506B2 (fr) | 1997-12-23 | 2019-08-21 | Pfizer Ireland Pharmaceuticals | Procedures permettant d'extraire et d'isoler des polysaccharides capsulaires bacteriens destines a etre utilises seuls, en tant que vaccins ou, lies a des proteines, en tant que vaccins conjugues |
CN1263510C (zh) * | 1998-08-19 | 2006-07-12 | 巴克斯特健康护理股份有限公司 | 多糖-蛋白质缀合物或寡糖-蛋白质缀合物、其制备方法及其应用 |
RU2249463C2 (ru) * | 1998-08-19 | 2005-04-10 | Бакстер Хелфкэа С.А. | Иммуногенный конъюгат бета-пропионамид-связанного полисахарида с белком, использующийся в качестве вакцины |
US6436653B1 (en) | 1998-12-15 | 2002-08-20 | Exiqon A/S | Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces |
US7083777B1 (en) * | 1999-04-02 | 2006-08-01 | The Brigham And Women's Hospital, Inc. | Immunomodulating polymers |
US6518037B2 (en) * | 1999-11-12 | 2003-02-11 | University Of Iowa Research Foundation | Two-component system that controls bacterial membrane synthesis |
GB9928196D0 (en) * | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
GB0011108D0 (en) * | 2000-05-08 | 2000-06-28 | Microscience Ltd | Virulence gene and protein and their use |
SV2003000753A (es) | 2000-12-05 | 2003-06-16 | Brigham & Womens Hospital | Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico |
CN1306956C (zh) * | 2001-04-17 | 2007-03-28 | 希龙公司 | 诱导功能活性抗体的脑膜炎球菌b抗原表位的分子模拟物 |
GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
GB0121591D0 (en) * | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
AR045702A1 (es) | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
NZ535968A (en) * | 2002-03-26 | 2006-08-31 | Chiron S | Modified saccharides having improved stability in water |
MXPA04011248A (es) * | 2002-05-14 | 2005-02-17 | Chiron Srl | Vacunas mucosales en combinacion para la meningitis bacteriana. |
RU2364418C2 (ru) * | 2002-08-02 | 2009-08-20 | ГлаксоСмитКлайн Байолоджикалз с.а. | ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB- |
GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
EP1638581A2 (fr) | 2003-03-31 | 2006-03-29 | The Brigham And Women's Hospital, Inc. | Immunomodulateurs zwitterioniques destines au traitement de l'asthme et des allergies |
US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
US7807824B2 (en) | 2003-08-12 | 2010-10-05 | Lipoxen Technologies Limited | Sialic acid derivatives for protein derivatisation and conjugation |
AU2005258301A1 (en) * | 2004-06-23 | 2006-01-05 | Children's Hospital & Research Center At Oakland | Polysaccharide derivatives and uses in induction of an immune response |
US8148335B2 (en) | 2004-06-23 | 2012-04-03 | Children's Hospital & Research Center Oakland | De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
GB0428394D0 (en) * | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
ES2377075T5 (es) | 2005-06-27 | 2016-04-29 | Glaxosmithkline Biologicals S.A. | Composición inmunogénica |
WO2007092451A2 (fr) | 2006-02-06 | 2007-08-16 | The Brigham And Women's Hospital, Inc. | Polysaccharides zwitterioniques pour favoriser la maturation du système immunitaire et la santé |
GB0611914D0 (en) | 2006-06-15 | 2006-07-26 | Teti Giuseppe | Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide |
EP1872791A1 (fr) * | 2006-06-30 | 2008-01-02 | Institut Pasteur | Utilisation de polysaccharides bactériens pour empêcher la formation d'un film biologique |
WO2008157590A1 (fr) * | 2007-06-20 | 2008-12-24 | Baxter International Inc. | Polysaccharides modifiés pour vaccins conjugués |
ES2664753T3 (es) | 2007-12-07 | 2018-04-23 | Glaxosmithkline Biologicals Sa | Composiciones de inducción de respuestas inmunes |
WO2010083477A2 (fr) | 2009-01-16 | 2010-07-22 | University Of Maryland, Baltimore | Vaccin à large spectre contre les salmonelles non typhoïdiques |
WO2013009945A1 (fr) | 2011-07-12 | 2013-01-17 | The Brigham And Women's Hospital, Inc. | Compositions de psa contenant des lipides, procédés d'isolement et procédés pour les utiliser |
EP2752403A1 (fr) * | 2013-01-08 | 2014-07-09 | Sika Technology AG | Amine pour résines époxy à faibles émissions |
EP3337321A4 (fr) | 2015-08-19 | 2019-07-17 | President and Fellows of Harvard College | Compositions de psa lipidés et procédés associés |
US11491181B2 (en) | 2016-07-15 | 2022-11-08 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
CA3051801A1 (fr) * | 2017-01-31 | 2018-08-09 | Pfizer Inc. | Compositions de neisseria meningitidis et methodes associees |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4057685A (en) * | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
US4673574A (en) * | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US4619828A (en) * | 1982-07-06 | 1986-10-28 | Connaught Laboratories, Inc. | Polysaccharide exotoxoid conjugate vaccines |
US4496538A (en) * | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
US4644059A (en) * | 1982-07-06 | 1987-02-17 | Connaught Laboratories, Inc. | Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine |
US4695624A (en) * | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
US4727136A (en) * | 1985-10-01 | 1988-02-23 | Canadian Patents And Development Ltd. | Modified meningococcal group B polysaccharide for conjugate vaccine |
WO1991008772A1 (fr) * | 1989-12-14 | 1991-06-27 | National Research Council Of Canada | Vaccin conjugue ameliore a base de polysaccharide de meningocoque |
-
1990
- 1990-12-13 WO PCT/CA1990/000437 patent/WO1991008772A1/fr active IP Right Grant
- 1990-12-13 AT AT91900142T patent/ATE121947T1/de not_active IP Right Cessation
- 1990-12-13 RO RO92-0789A patent/RO111416B1/ro unknown
- 1990-12-13 DK DK91900142.0T patent/DK0504202T3/da active
- 1990-12-13 RU SU5052391A patent/RU2105568C1/ru active
- 1990-12-13 HU HU9201966A patent/HU9201966D0/hu unknown
- 1990-12-13 HU HU9201966A patent/HU218146B/hu unknown
- 1990-12-13 JP JP3500908A patent/JP2637845B2/ja not_active Expired - Fee Related
- 1990-12-13 CA CA002071811A patent/CA2071811C/fr not_active Expired - Fee Related
- 1990-12-13 DE DE69019164T patent/DE69019164T2/de not_active Expired - Fee Related
- 1990-12-13 AU AU68987/91A patent/AU641715B2/en not_active Ceased
- 1990-12-13 EP EP91900142A patent/EP0504202B1/fr not_active Expired - Lifetime
- 1990-12-13 KR KR1019920701403A patent/KR0158436B1/ko not_active Expired - Fee Related
- 1990-12-13 BR BR909007917A patent/BR9007917A/pt not_active Application Discontinuation
- 1990-12-13 ES ES91900142T patent/ES2071288T3/es not_active Expired - Lifetime
- 1990-12-14 PH PH41724A patent/PH30305A/en unknown
- 1990-12-14 CZ CS906284A patent/CZ283530B6/cs unknown
- 1990-12-14 IE IE451390A patent/IE68414B1/en not_active IP Right Cessation
- 1990-12-14 YU YU24391A patent/YU24391A/sh unknown
- 1990-12-14 PL PL90302476A patent/PL166659B1/pl not_active IP Right Cessation
- 1990-12-14 NZ NZ236471A patent/NZ236471A/en unknown
- 1990-12-14 ZA ZA9010065A patent/ZA9010065B/xx unknown
- 1990-12-14 IN IN1033/CAL/90A patent/IN171747B/en unknown
- 1990-12-14 PL PL90288271A patent/PL166035B1/pl not_active IP Right Cessation
- 1990-12-14 SI SI9110243A patent/SI20008B/sl not_active IP Right Cessation
- 1990-12-14 CN CN90110444A patent/CN1049223C/zh not_active Expired - Fee Related
- 1990-12-14 AR AR90318627A patent/AR243934A1/es active
- 1990-12-14 IL IL9667690A patent/IL96676A/en not_active IP Right Cessation
-
1992
- 1992-06-12 NO NO922316A patent/NO305275B1/no unknown
- 1992-06-12 FI FI922737A patent/FI104539B/fi active
- 1992-10-02 HR HRP-243/91A patent/HRP920872A2/hr not_active Application Discontinuation
-
1993
- 1993-11-22 CN CN93114763A patent/CN1036522C/zh not_active Expired - Fee Related
- 1993-11-22 CN CN93119467A patent/CN1036504C/zh not_active Expired - Fee Related
- 1993-11-22 CN CN93114764A patent/CN1072506C/zh not_active Expired - Fee Related
-
1994
- 1994-05-05 US US08/238,600 patent/US5576002A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/485,623 patent/US5683699A/en not_active Expired - Lifetime
-
1997
- 1997-07-17 NO NO973311A patent/NO307835B1/no unknown
- 1997-10-17 US US08/953,771 patent/US5902586A/en not_active Expired - Fee Related
-
1999
- 1999-09-09 FI FI991917A patent/FI19991917L/fi unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH30305A (en) | Improved meningococcal polysaccharide conjugate vaccine | |
GB8907914D0 (en) | Vaccine preparation | |
HU896283D0 (en) | Colon-selective, peroral medical preparation | |
HUP0103100A3 (en) | Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide | |
GB8924438D0 (en) | Vaccine composition | |
HUP9802664A3 (en) | Modified meningococcal polysaccharide conjugate vaccines and modified polysaccharides | |
EP0454735A4 (en) | Vaccine composition | |
GB8921470D0 (en) | Vaccines | |
EP0468714A3 (en) | Peptide-polysaccharide-protein conjugate vaccines | |
PT86286A (en) | Conjugate vaccine | |
AU1118888A (en) | Conjugate malaria vaccine | |
GB9017370D0 (en) | Tuberculosis vaccine | |
GB8918689D0 (en) | 25/15 vaccine | |
GB2232681B (en) | Nitro-p-phenylenediamine derivatives | |
EP0504136A4 (en) | Tolerogenic immunoglobulin-protein conjugates | |
AP9000165A0 (en) | Vaccine composition | |
HU9303207D0 (en) | Liposomal polysaccharide vaccines | |
PL346645A1 (en) | IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE | |
ZA907863B (en) | Vaccine conjugate | |
ZA92536B (en) | Pneumococcal polysaccharide conjugate vaccine | |
AU5560886A (en) | Klebsiella capsular polysaccharide vaccine | |
EP0453452A4 (en) | Vaccine | |
ZA88792B (en) | Conjugate malaria vaccine | |
GB8922651D0 (en) | Vaccine | |
ZA909516B (en) | Novel vaccine |